Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple daily drink help stroke patients recover?

NCT ID NCT05474105

Knowledge-focused Sponsor: Barts & The London NHS Trust Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed pilot study tested whether giving a daily multi-nutrient drink to people who recently had an ischemic stroke is practical and acceptable. Twenty-four adults were split into two groups: one received the drink plus standard care, the other standard care alone. The main goal was to see if a larger trial is possible, not to prove the drink works.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
oral nutritional supplement (multi-nutrient medical food drink)
What this could lead to
If the supplement shows promise in a future larger trial, it could point toward a simple nutritional approach to support brain recovery after a stroke.
What could go wrong
This was a very small pilot study (24 people) focused only on feasibility, not on proving the supplement works. Many similar nutritional interventions have failed to show clear benefits in larger trials.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

24 people

The number who actually took part.

Started

Apr 2023

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age \>18 and \<80 * Acute ischaemic stroke (within 24 h of onset), including the following subtypes according to the Trial of Org 10172 in Acute Stroke Treatment (TOAST) classification: large-artery atherosclerosis, cardio-embolism, small-vessel occlusion, stroke of undetermined aetiology OR Acute ischaemic stroke (within 24 h of onset) caused by arterial dissection. * Pre-morbid (modified Rankin Scale) mRS of ≤2 * National Institutes of Health Stroke Scale (NIHSS) score \>4 * CT ASPECT score of ≥6 on presentation CT * Expected ability to provide consent * Ability to drink the ONS product within 7 days of incident stroke Exclusion Criteria: * Allergies to fish oil/milk/soya * Known history of galactosaemia * Patients that develop malignant middle cerebral artery (MCA) syndrome * Current or previous haemorrhagic stroke including sub-arachnoid haemorrhage * Patient with nasogastric (NG) tube * Patients with dysphagia (routinely tested) who cannot drink the medical food * Known malignancy * Known pre-existing neurological disease including multiple sclerosis, Alzheimer's disease, Parkinson's disease, previous strokes * Pregnant or breastfeeding * Inability to complete the follow-up and/or Investigators uncertainty about the ability to complete the follow-up * Chronic renal disease Stage 3b and above (I.e. Glomerular filtration rate (GFR) \< 44ml/min) * Ischaemic stroke of other determined aetiology as classified by the TOAST classification (not including stroke caused by arterial dissection). * Unable to receive enteral nutrition

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ischemic stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Ischemic stroke

Contacts and locations

Locations

  • Royal London Hospital

    London, E11FR, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.